VAR2 Pharmaceuticals co-authors have published an article in Nature Communications entitled “Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding”. This article reports the high-resolution structure of our proprietary cancer targeting molecule, VAR2CSA, and sheds light on the complex interaction between VAR2CSA and oncofetal chondroitin sulfate in tumors […]
